1. Home
  2. BXMT vs MESO Comparison

BXMT vs MESO Comparison

Compare BXMT & MESO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackstone Mortgage Trust Inc.

BXMT

Blackstone Mortgage Trust Inc.

N/A

Current Price

$13.55

Market Cap

2.5B

Sector

Real Estate

ML Signal

N/A

Logo Mesoblast Limited

MESO

Mesoblast Limited

N/A

Current Price

$14.86

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BXMT
MESO
Founded
1966
2004
Country
United States
Australia
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.0B
IPO Year
1998
2005

Fundamental Metrics

Financial Performance
Metric
BXMT
MESO
Price
$13.55
$14.86
Analyst Decision
Buy
Strong Buy
Analyst Count
5
1
Target Price
$21.38
N/A
AVG Volume (30 Days)
1.7M
162.8K
Earning Date
04-29-2026
02-26-2026
Dividend Yield
9.85%
N/A
EPS Growth
154.70
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$629.74
Revenue Next Year
N/A
$30.65
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.34
$13.05
52 Week High
$20.67
$21.50

Technical Indicators

Market Signals
Indicator
BXMT
MESO
Relative Strength Index (RSI) 35.67 36.80
Support Level N/A $14.31
Resistance Level $14.27 $16.06
Average True Range (ATR) 0.28 0.39
MACD 0.01 -0.33
Stochastic Oscillator 31.62 0.78

Price Performance

Historical Comparison
BXMT
MESO

About BXMT Blackstone Mortgage Trust Inc.

Blackstone Mortgage Trust Inc is an externally managed real estate finance company that originates, acquires, and manages senior loans and other debt or credit-oriented investments collateralized by or relating to commercial real estate in North America, Europe, and Australia. Its portfolio is composed of senior loans secured by high-quality, institutional assets located in main markets, and sponsored by experienced, well-capitalized real estate investment owners and operators. The group finances its investments in a variety of ways, including borrowing under secured credit facilities, issuing collateralized loan obligations, or CLOs, other securitization transactions, syndicating senior loans and/or participations, and other forms of asset-level financing.

About MESO Mesoblast Limited

Mesoblast Ltd is a commercial-stage biotechnology company engaged in developing and commercializing allogeneic (off-the-shelf) cellular medicines for severe inflammatory conditions. Its commercial product, Ryoncil (remestemcel-L-rknd), is FDA-approved for steroid-refractory acute graft-versus-host disease in pediatric patients. The company is also developing Ryoncil for additional inflammatory indications. Its rexlemestrocel-L platform is being developed for chronic low back pain associated with degenerative disc disease and chronic heart failure. The company operates as a single segment focused on its allogeneic cellular medicines platform.

Share on Social Networks: